Accelerate Drug Development

Accelerate Drug Development

Implementing a clinical simulation strategy brings clear benefits

According to a recent survey, 86% of companies have seen pre-clinical PK/PD analysis impact drug development.

Benefits to gain from successful implementation of simulation strategies can be enormous. Trial simulation strategies have been successfully employed to:

  • Help determine the impact of formulation changes on clinical response and assist in optimal formulation selection based on both pharmacokinetic and pharmacodynamic considerations
  • Help determine the most robust clinical trial design with respect to study design, patient numbers and number of dose groups, thereby minimizing time and cost
  • Gain early insight on future dosing regimens, thereby expediting protocol development and compressing development timelines
  • Risk mitigation potential offered in late stage clinical development where the use of modeling and simulation can substantially improve the quality of critical go/no go drug development decisions and help identify the optimal dose and dosing regimen to take forward into costly registration trials

Our quantitative modeling and simulation technology can be leveraged to help you efficiently achieve the following developmental goals:

  • Correct selection of the drug dose and schedule
  • Designing fewer, smaller, more efficient clinical trials 
  • Improving interactions with regulatory authorities 
  • Developing therapeutics with better benefit/risk profiles 
  • Attracting investor funding or securing a development partner 

By choosing a team that specializes in clinical trial simulation and modeling, pharmaceutical companies can expect a higher return on investment, and are able to avoid hazards in their drug development program, including unnecessary cost of development, increased time to approval, or in some cases both.

With Synteract’s recent acquisition of KinderPharm with its extended team of PKPD scientists, we can bring advanced pharmacometric modeling and clinical trial simulation technologies to both adult and pediatric drug development across the spectrum of therapeutic areas.

Contact us to learn more about how Synteract can help with implementing appropriate PK/PD models or other aspects of modeling and simulation for your next clinical trial.

x

Submit RFI / RFP

..
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

 

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Opt In

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required